The Indian government is planning a subsidy scheme for mid-size drugmakers to bring their facilities in line with WHO manufacturing standards. Most already comply with the standards of the country's Drugs and Cosmetics Act, so officials believe that the facility upgrades will be of limited scope. A proposal now in the works provides an interest subsidy to the qualifying companies. Article